NovaBay Pharmaceuticals, Inc (NBY) insider trading
Every open-market stock purchase and sale by NovaBay Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $0 over the last 12 months (1 sale).
- Last insider buy: Framework Ventures IV L.P. (10% owner), n/a, 12 months ago.
Last 12 months: insiders bought $0 (3 buys) and sold $0 (1 sale). Last close $1.95 on Apr 1, 2026.
Recent NBY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 21, 2025 | David E. Lazar (10% owner) | Bought (not open market) | — |
| Oct 21, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
| Oct 21, 2025 | Framework Ventures IV L.P. (10% owner) | Bought (not open market) | — |
| Oct 21, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
| Oct 21, 2025 | David E. Lazar (10% owner) | Bought (not open market) | — |
| Oct 16, 2025 | Framework Ventures IV L.P. (10% owner) | Bought (not open market) | — |
| Oct 16, 2025 | David E. Lazar (10% owner) | Sold | — |
| Oct 16, 2025 | Framework Ventures IV L.P. (10% owner) | Bought (not open market) | — |
| Oct 16, 2025 | Framework Ventures IV L.P. (10% owner) | Bought (not open market) | — |
| Oct 16, 2025 | Framework Ventures IV L.P. (10% owner) | Bought (not open market) | — |
| Oct 16, 2025 | Framework Ventures IV L.P. (10% owner) | Bought | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
| Oct 16, 2025 | Michael John Kazley (CEO) | Bought (not open market) | — |
Who's trading NBY
- Michael John Kazley, CEO: bought $0 (2 buys), last Oct 21, 2025
- Framework Ventures IV L.P., 10% owner: bought $0 (1 buy), last Oct 21, 2025
- David E. Lazar, 10% owner: sold $0 (1 sale), last Oct 21, 2025
Get free alerts when an insider at NovaBay Pharmaceuticals, Inc files a new trade →